abstract |
The present invention relates to novel 4-phenyl-piperazin-1-yl-alkyl-benzimidazol-2-one derivatives of structure (I) useful as monoamine neurotransmitter reuptake inhibitors. In another aspect, the invention relates to the use of these compounds in a method for treatment and to pharmaceutical compositions comprising the compounds of the invention. |